This comprehensive five-country report contains 500 pages, 120 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European coagulation testing market during the next five years.
The report explores business and technological trends in France, Germany, Italy, Spain, and the UK; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Coagulation Tests
Activated Clotting Time (ACT) (1), Activated Protein C Resistance,
Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,
D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX,
Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,
Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,
Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Prothrombin Time (PT),
Von Willebrand's Factor Fav/Ag, and others.
Geographic Coverage
France, Germany, Italy, Spain, UK
Sales and Market Share Analysis
- Sales and market shares of major
instrument and reagent suppliers.
Competitive Assessments
- Extensive strategic profiles of
major suppliers and emerging market entrants.
Market Segmentation Analysis
- Comprehensive market
segmentation analysis, including:
- Hospitals
- Commercial/Private Laboratories
- Physician Offices
- Ambulatory Care Centers
- Test volume forecasts for over 40 major procedures,
by country and market segment.
Current and Emerging Products
- Review of established and emerging procedures.
- Comparison of automated and semi-automated
analyzers from Diagnostica Stago, Helena, IL,
Siemens, Sysmex and other suppliers.
Technology Review
- Analysis of current and emerging technologies
and their potential market applications.
- Comprehensive lists of companies developing
or marketing new technologies and products by test.
Strategic Recommendations
- Product development and business expansion
opportunities with significant market appeal.
- “Ideal” product models with tentative
prices and operating characteristics.
- Alternative market penetration
strategies for instrument and reagent suppliers.
- Potential market entry barriers and risks
Contains 500 pages and 120 tables